Interpretation of the Meaningfulness of Symptom Reduction with Vibegron in Patients with Overactive Bladder: Analyses from EMPOWUR-Reference-Cited by-同舟云学术

Interpretation of the Meaningfulness of Symptom Reduction with Vibegron in Patients with Overactive Bladder: Analyses from EMPOWUR

Published:2021-12-18 Issue: Volume: Page:
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Frankel Jeffrey,Staskin David,Varano Susann,Kennelly Michael,Newman Diane K.,Rosenberg Matt T.,Jankowich Rachael A.,Shortino Denise,Mudd Paul N.,Girman Cynthia J.

Funder

Urovant Sciences

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12325-021-01972-8.pdf

Reference37 articles.

1. Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4–20.

2. Gormley EA, Lightner DJ, Burgio KL, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. American Urological Association; 2019.

3. Coyne KS, Sexton CC, Vats V, Thompson C, Kopp ZS, Milsom I. National community prevalence of overactive bladder in the United States stratified by sex and age. Urology. 2011;77(5):1081–7.

4. Rantell A, Cardozo L, Khullar V. Personal goals and expectations of OAB patients in the UK. Neurourol Urodyn. 2017;36(4):1194–200.

5. Kinsey D, Pretorius S, Glover L, Alexander T. The psychological impact of overactive bladder: a systematic review. J Health Psychol. 2016;21(1):69–81.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Online Group-based Pelvic Floor Muscle Training for Urinary Incontinence in Older Women: a Pilot Study;International Urogynecology Journal;2024-02-05

2. What is the best first choice oral drug therapy for OAB?;Neurourology and Urodynamics;2024-01-25

3. Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults;Cochrane Database of Systematic Reviews;2023-05-09

4. Study design of a phase 4, real-world study (COMPOSUR) to evaluate vibegron in patients with overactive bladder;BMC Urology;2023-04-24

5. Efficacy and Safety of Vibegron for the Treatment of Overactive Bladder in Women: A Subgroup Analysis From the Double-Blind, Randomized, Controlled EMPOWUR Trial;Urogynecology;2022-10-21